Tisdag 28 Oktober | 10:25:23 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2026-05-07 N/A Årsstämma
2026-02-10 N/A Bokslutskommuniké 2025
2025-11-06 08:10 Kvartalsrapport 2025-Q3
2025-07-22 - Kvartalsrapport 2025-Q2
2025-05-13 - Kvartalsrapport 2025-Q1
2025-09-29 10:00:00

Due to changes in share ownership in Asker Healthcare Group, Richard Torgerson, Nordea Funds, joins the nomination committee and replaces Carina Silberg, Alecta.

The Nomination Committee consists of:
Johan Hesser, Nalka Invest
Patrik Jonsson, SEB Funds AB
Richard Torgerson, Nordea Funds
Håkan Björklund, Chairman of the Board of Asker Healthcare Group AB

Shareholders who would like to submit proposals to the Nomination Committee can do so by e-mail to nomination.committee@asker.com, or by post to Asker Healthcare Group, Attn. Nomination Committee, Svärdvägen 3A, SE-182 33 Danderyd, Sweden. In order for proposals to be considered by the nomination committee, they should be received in due time before the Annual General Meeting, and no later than 23 January 2026.

The Annual General Meeting of Asker Healthcare Group AB will be held on 7 May 2026.

For further information, please contact:
Emma Rheborg, Head of Communication Asker Healthcare Group
Phone: +46 73 313 62 17
E-mail: emma.rheborg@asker.com

The information was submitted for publication, through the agency of the contact person set out above, at 10:00 CEST on 29 September 2025.

Asker Healthcare Group is a partner to caregivers and patients across Europe providing medical products and solutions. We build and acquire leading companies that together support the healthcare system to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain. We are a European healthcare group that combines the entrepreneurial drive of strong local companies, with the abilities and collected knowledge of a large group - driving progress in the healthcare sector. The group has more than 4 000 employees in 17 countries and revenues amounting to SEK 16 billion.